LeMaitre Vascular

LeMaitre Vascular is a publicly traded, global medical device company with a singular mission: to equip vascular surgeons with innovative, reliable tools to treat peripheral vascular disease. Founded in 1983 by Dr. George D. LeMaitre, the company has grown from a family-owned business into a $2.5B entity through a surgeon-centric culture and a disciplined acquisition strategy that has expanded its portfolio into biologics and endovascular segments. Its strategy focuses on direct global commercialization, deep clinical engagement, and a commitment to solving specific, high-need surgical challenges, resulting in a durable, high-margin business with a strong competitive moat.

A surgeon-centric clinical expertise platform focused on designing and acquiring mechanical devices and biologic implants for specific vascular surgical challenges, spanning arterial reconstruction, biologics, and endovascular procedures.

LeMaitre competes in specialized niches against larger diversified medtech companies (e.g., Medtronic, Getinge) and smaller private firms. Its competitive advantage stems from deep surgeon relationships, a focused product portfolio of mission-critical tools, and a direct global sales force dedicated solely to vascular surgeons.